Alignment of PrEP Use With HIV Risk in Young Women and Men

NCT04664998 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

212

Enrollment

OTHER

Sponsor class

Conditions

Pre-Exposure Prophylaxis
Sexually Transmitted Diseases, Bacterial
HIV Infections

Interventions

DRUG: Daily oral PrEP
DRUG: Daily oral PrEP

Sponsor

University of Washington

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]